Anterior Pituitary

  • William H. Daughaday


The adenohypophysis, despite its small size, should be considered functionally as at least five different glands, each with separate regulatory mechanisms and with unique disorders. For the purposes of this discussion, we will consider these components in the following order: (1) secretion of corticotropin and related peptides; (2) thyrotropin secretion; (3) gondotropin secretion; (4) prolactin secretion; and (5) somatotropin secretion. This review of contributions during the past year makes no pretense of being comprehensive. The large number of papers and the interests of this author have dictated the selection of papers for consideration.


Growth Hormone Prolactin Level Anterior Pituitary Growth Hormone Secretion Acromegalic Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Eipper, B. A., Mains, R. E., and Guenzi, D., 1976, High molecular weight forms of adrenocorticotropic hormone are glycoproteins, J. Biol. Chem. 251:4121–4126.PubMedGoogle Scholar
  2. 2.
    Orth, D. N., and Nicholson, W. E., 1977, High molecular weight forms of human ACTH are glycoproteins,J.Clin. Endocrinol. Metab. 44:214–217.PubMedGoogle Scholar
  3. 3.
    Guillemin, R., 1976, Physiological and clinical significance of hypothalamic and extrahypothalamic brain peptides, Triangle (Engl. Ed.) 15:1–7.Google Scholar
  4. 4.
    Silman, R. E., Chard, T., Lowry, P. J., Smith, I., and Young, I. M., 1976, Human foetal pituitary peptides and parturition, Nature (London) 260:716–718.Google Scholar
  5. 5.
    Lowry, P. J., Rees, L. H., Tomlin, S., Gillies, G., and Landon, J., 1976, Chemical characterization of ectopic ACT H purified from a malignant thymic carcinoid tumor,J.Clin. Endocrinol Metab. 43:831–835.PubMedGoogle Scholar
  6. 6.
    Hirata, Y., Matsukura, S., Imura, H., Nakamura, M., and Tanaka, A., 1976, Size heterogeneity of β-MSH in ectopic ACTH-producing tumors: Presence of β-LPH-like peptide,J.Clin. Endocrinol. Metab. 42:33–40.PubMedGoogle Scholar
  7. 7.
    Baumann, G., Walser, A., Desaulles, P. A., Paesi, F. J. A., and Geller, L., 1976, Corticotropic action of an intra-nasally applied synthetic ACTH derivative, J. Clin. Endocrinol. Metab. 42:60–63.PubMedGoogle Scholar
  8. 8.
    Smith, A. G., Shuster, S., Thody, A. J., Alvarezude, F., and Kerr, D. N., 1976, Role of the kidney, in regulating plasma immunoreactive beta-melanocyte-stimulating hormone, Br. Med. J. 1:874–876.PubMedGoogle Scholar
  9. 9.
    Limjuco, R. A., Sherman, L., and Kolodny, H. D., 1976, Isolated ACTH deficiency, N. Y. State J. Med. 76:439–444.PubMedGoogle Scholar
  10. 10.
    Laron, Z., Karp, M., Pertzelan, A., and Frankel, J., 1970, ACTH deficiency in children and adolescents (clinical and psychological aspects), Prog. Brain Res. 32:305–315.PubMedGoogle Scholar
  11. 11.
    Baba, S., Takase, S., Uenoyama, R., Morita, S., Mizoi, S., and Hishida, S., 1976, Isolated corticotrophin-deficiency found through alcohol-induced hypoglycemic coma, Horm. Metab. Res. 8:274–278.PubMedGoogle Scholar
  12. 12.
    Yamamoto, T., Ogihara, T., Miyai, K., Kumahara, Y., and Hirata, Y., 1976, Co-existent primary hypothyroidism and isolated ACTH deficiency, Acta Endocrinol. 82:467–474.PubMedGoogle Scholar
  13. 13.
    Parker, D. C., Pekary, A. E., and Hershman, J. M., 1976, Effect of normal and reversed sleep-wake cycles upon nyctohemeral rhythmicity of plasma thyrotropin: Evidence suggestive of an inhibitory influence in sleep,J.Clin. Endocrinol. Metab. 43:318–329.PubMedGoogle Scholar
  14. 14.
    Weeke, J., and Laurberg, P., 1976, Diurnal TSH variations in hypothyroidism,J.Clin. Endocrinol. Metab. 43:32–37.PubMedGoogle Scholar
  15. 15.
    Hood, S., Vaughan-Jackson, J. D., and Farid, N. R., 1976, Inappropriate TSH secretion. Paradoxical rise in serum TSH in response to thyroxine therapy,J.Clin. Endocrinol. Metab. 43:1360–1364.PubMedGoogle Scholar
  16. 16.
    Golstein, J., Vanhaelst, L., Camus, M., and Glinoer, D., 1976, Paradoxical modulation of thyrotrope responsiveness to TRH during the treatment of thyrotoxic patients: Apparent absence of feed-back regulation, Horm. Metab. Res. 8:128–31.PubMedGoogle Scholar
  17. 17.
    McCarten, K. M., and Kuhns, L. R., 1976, The area and volume of the sella turcica in childhood primary hypothyroidism, Radiology 119:645–650.PubMedGoogle Scholar
  18. 18.
    Leiba, S., Shani, M., Zahavi, I., Samuel, R., Borohowsky, S., and Ber, A., 1976, Secondary pituitary insufficiency; Report of three cases of ectopia or hemiagenesis of the thyroid gland, Arch. Intern Med. 136:1010–1015.PubMedGoogle Scholar
  19. 19.
    Vagenakis, A. G., Dole, K., and Braverman, L. E., 1976, Pituitary enlargement, pituitary failure, and primary hypothyroidism, Ann. Intern. Med. 85:195–198.PubMedGoogle Scholar
  20. 20.
    Keye, W. R., Jr., Yuen, B. H., Knopf, R. F., and Jaffe, R. B., 1976, Amenorrhea, hyperprolactinemia and pituitary enlargement secondary to primary hypothyroidism. Successful treatment with thyroid replacement, Obstet. Gynecol. 48:697–702.PubMedGoogle Scholar
  21. 21.
    Ramey, J. N., Burrow, G. N., Spaulding, S. W., Donabedian, R. K., Speroff, L., and Frantz, A. G., 1976, The effect of aspirin and indömethacin on the TRH response in man,J.Clin. Endocrinol. Metab. 43:107–114.PubMedGoogle Scholar
  22. 22.
    Sowers, J. R., Hershman, J. M., Pekary, A. E., Nair, M. G., and Baugh, C. M., 1976, Effect of N3im-methyl-thyrotropin releasing hormone on the human pituitary-thyroid axis,J.Clin. Endocrinol. Metab. 43:741–748.PubMedGoogle Scholar
  23. 23.
    Sowers, J. R., Hershman, J. M., Carlson, H. E., Pekary, A. E., Reed, A. W., Nair, M. G., and Baugh, C. M., 1976, Dose-response of prolactin and thyrotropin to N3im-methyl-thyrotropin releasing hormone in euthyroid men, J. Clin. Endocrinol. Metab. 43:856–860.PubMedGoogle Scholar
  24. 24.
    Vale, W., Rivier, J., and Burgus, R., 1971, Synthetic TRF (thyrotropin releasing factor) analogues: II. pGlu-N3imme-His-Pro-NH2: A synthetic analogue with specific activity greater than that of TRF, Endocrinology 89:1485–1488.PubMedGoogle Scholar
  25. 25.
    Czernichow, P., Dauzet, M. C., Broyer, M., and Rappaport, R., 1976, Abnormal TSH, PRL and GH response to TSH releasing factor in chronic renal failure,J.Clin. Endocrinol Metab. 43:630–637.PubMedGoogle Scholar
  26. 26.
    Boehm, T. M., Dimond, R. C., and Wartofsky, L., 1976, Isolated thyrotropin deficiency with thyrotropin-releasing-hormone induced TSH secretion and thyroidal release,J.Clin. Endocrinol. Metab. 43:1041–1046.PubMedGoogle Scholar
  27. 27.
    Graesslin, D., Leidenberger, F. A., Lichtenberg, V., Glismann, D., Hess, N., Czygan, P. J., and Bettendorf, G., 1976, Existence of big and little forms of luteinizing hormone in human serum, Acta Endocrinol. 83:466–482.PubMedGoogle Scholar
  28. 28.
    Leidenberger, F. A., Graesslin, D., Scheel, H. J., Hess, N., Lichtenberg, V., and Bettendorf, G., 1976, A low molecular weight substance obtained from serum which has luteinizing hormone like activity (“mini LH”), J.Clin. Endocrinol. Metab. 43:1410–1413.PubMedGoogle Scholar
  29. 29.
    Thorell, J. I., Jeppsson, S., and Holmström, B., 1976, Production of specific antisera for radioimmunoassay of human luteinizing hormone (LH) in the presence of human chorionic gonadotropin (hCG), J.Clin. Endocrinol. Metab. 43:708–711.PubMedGoogle Scholar
  30. 30.
    Wollensen, F., Swerdloff, R. S., and Odell, W. D., 1976, LH and FSH responses to luteinizing-re leasing hormone in normal human males, Metabolism 25:845–863.Google Scholar
  31. 31.
    Wollensen, F., Swerdloff, R. S., and Odell, W. D., 1976, LH and FSH responses to luteinizing releasing hormone in normal fertile women, Metabolism 25:1275–1285.Google Scholar
  32. 32.
    Koninckx, P., De Hertogh, R., Heyns, W., Meulepas, E., Brosens, L., and De Moor, P., 1976, Secretion rates of LH and FSH during infusion of LH-FSH/RH in normal women and in patients with secondary amenorrhea: Suggestive evidence for two pools of LH and FSH,J.Clin. Endocrinol. Metab. 43:159–167.PubMedGoogle Scholar
  33. 33.
    Beitins, I. Z., O’Loughlin, K., Ostrea, T., and McArthur, J. W., 1976, Gonadotropin determinations in timed 3-hour urine collections during the menstrual cycle and LHRH testing, J.Clin. Endocrinol. Metab. 43:46–55.PubMedGoogle Scholar
  34. 34.
    Reiter, E. O., Root, A. W., and Duckett, G. E., 1976, The response of pituitary gonadotropes to a constant infusion of luteinizing hormone-releasing hormone (LHRH) in normal prepubertal and pubertal children and in children with abnormalities of sexual development,J.Clin. Endocrinol. Metab. 43:400–411.PubMedGoogle Scholar
  35. 35.
    Gennser, G., Liedholm, P., and Thorell, J., 1976, Pituitary hormone levels in plasma of the human fetus after administration of LRH, J.Clin. Endocrinol. Metab. 43:470–473.PubMedGoogle Scholar
  36. 36.
    Jeppsson, S., and Rannevik, G., 1976, Studies on the gonadotropin response after administration of LH-FSH-releasing hormone (LRH) during pregnancy and after therapeutic abortion in the second trimester, Am. J. Obstet. Gynecol. 125:484–490.PubMedGoogle Scholar
  37. 37.
    Reyes, F. I., Winter, J. S. D., and Faiman, C., 1976, Pituitary gonadotropin function during human pregnancy: Serum FSH and LH levels before and after LHRH administration,J.Clin. Endocrinol. Metab. 42:590–592.PubMedGoogle Scholar
  38. 38.
    Keye, W. R., Jr., and Jaffe, R. B., 1976, Changing patterns of FSH and LH response to gonadotropin-releasing hormone in the puerperium, J. Clin. Endocrinol. Metab. 42:1133–1138.PubMedGoogle Scholar
  39. 39.
    Andreassen, B., and Tyson, J. E., 1976, Role of the hypothalamic-pituitary-ovarian axis in puerperal infertility, J. Clin. Endocrinol. Metab. 42:1114–1122.PubMedGoogle Scholar
  40. 40.
    Angeli, A., Boccuzzi, G., Fonzo, D. B. D., Frajria, R., De Sanctis, C., and Ceresa, F., 1976, Effect of cyproterone acetate therapy on gonadotropin response to synthetic luteinizing hormone-releasing hormone (LRH) in girls with idiopathic precocious puberty,J.Clin. Endocrinol. Metab. 42:551–560.PubMedGoogle Scholar
  41. 4L.
    Lee, P. A., and Gareis, F. J., 1976, Gonadtropin and sex steroid response to lutenizing hormone-releasing hormone in patients with premature adrenarche, J.Clin. Endocrinol. Metab. 43:195–197.PubMedGoogle Scholar
  42. 42.
    Friend, J. N., Judge, D. M., Sherman, B. M., and Santen, R. J., 1976, FSH-secreting pituitary adenomas: Stimulation and suppression studies in two patients, J.Clin. Endocrinol. Metab. 43:650–657.PubMedGoogle Scholar
  43. 43.
    Snyder, P. J., and Sterling, F. H., 1976, Hypersecretion of LH and FSH by a pituitary adenoma, J.Clin. Endocrinol. Metab. 42:544–550.PubMedGoogle Scholar
  44. 44.
    Mortimer, R. H., Fleischer, N., Lev-Gur, M., and Freeman, R. G., 1976, Correlation between integrated LH and FSH levels and the response to luteinizing hormone releasing factor (LRF), J.Clin. Endocrinol. Metab. 43:1240–1249.PubMedGoogle Scholar
  45. 45.
    Katz, M., Pimstone, B. L., Carr, P. J., and Hendricks, S., 1976, Plasma gonadotropin and gonadotropin-releasing hormone levels after intranasal administration of gonadotropin releasing hormone, J.Clin. Endocrinol. Metab. 43:215–221.PubMedGoogle Scholar
  46. 46.
    Rebar, R., Judd, H. L., Yen, S. S. C., Rakoff, J., Vandenberg, G., and Naftolin, F., 1976, Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome,J.Clin. Invest. 57:1320–1329.PubMedGoogle Scholar
  47. 47.
    Martin-Comin, J., and Robyn, C., 1976, Comparative immunoenzymatic localization of prolactin and growth hormone in human and rat pituitaries, J.Histochem. Cytochem. 24:1012–1016.PubMedGoogle Scholar
  48. 48.
    Yamaji, T., Shimamoto, K., Ishibashi, M., Kosaka, K., and Orimo, H., 1976, Effect of age and sex on circulating and pituitary prolactin levels in human, Acta Endocrinol. (Copenhagen) 83:711–719.Google Scholar
  49. 49.
    Buckman, M. L., Kaminsky, N., Conway, M., and Peake, G. T., 1973, Utility of L-dopa and water loading in evaluation of hyperprolactinemia, J.Clin. Endocrinol. Metab. 36:911–919.PubMedGoogle Scholar
  50. 50.
    Adler, R. A., Noel, G. L., Wartofsky, L., and Frantz, A. G., 1975, Failure of oral water loading and intravenous hypotonic saline to suppress plasma prolactin in men, J.Clin. Endocrinol. Metab. 41:383–389.PubMedGoogle Scholar
  51. 51.
    Buckman, M. T., Peake, G. T., and Robertson, G., 1976, Hyperprolactinemia influences renal function in man, Metabolism 25:509–516.PubMedGoogle Scholar
  52. 52.
    Baumann, G., and Loriaux, D. L., 1976, Failure of endogenous prolactin to alter renal salt and water excretion and adrenal function in man, J. Clin. Endocrinol Metab. 43:643–649.PubMedGoogle Scholar
  53. 53.
    Horrobin, D. F., Manku, M. S., and Robertshaw, D., 1973, Water-losing action of antidiuretic hormone in the presence of excess Cortisol: Restoration of normal action by prolactin or by oxytocin,J.Endocrinol. 58:135–136.PubMedGoogle Scholar
  54. 54.
    Diefenbach, W. P., Carmel, P. W., Frantz, A. G., and Ferin, M., 1976, Suppression of prolactin secretion by L-Dopa in the stalk-sectioned rhesus monkey,J.Clin. Endocrinol. Metab. 43:638–642.PubMedGoogle Scholar
  55. 55.
    Robyn, C., and Vekemans, M., 1976, Influence of low dose oestrogen on circulation prolactin, LH and FSH levels in post-menopausal women, Acta Endocrinol. 83:9–14.PubMedGoogle Scholar
  56. 56.
    Buckman, M. T., Peake, G. T., and Srivastava, L. S., 1976, Endogenous estrogen modulates phenothiazine stimulated prolactin secretion, J.Clin. Endocrinol. Metab. 43:901–906.PubMedGoogle Scholar
  57. 57.
    Ehara, Y., Siler, T. M., and Yen, S. S. C., 1976, Effects of large doses of estrogen on prolactin and growth hormone release, Am. J. Obstet. Gynecol. 125: 455–458.PubMedGoogle Scholar
  58. 58.
    Sowers, J. R., McCallum, R. W., Hershman, J. M., Carlson, H. E., Sturdevant, R. A. L., and Meyer, N., 1976, Comparison of metoclopramide with other dynamic tests of prolactin secretion,J.Clin. Endocrinol. Metab. 43:679–681.PubMedGoogle Scholar
  59. 59.
    Judd, S. J., Lazarus, L., and Smythe, G., 1976, Prolactin secretion by metoclopramide in man,J.Clin Endocrinol. Metab. 43:313–317.PubMedGoogle Scholar
  60. 60.
    Jacobs, H. S., Franks, S., Murray, M. A. F., Hull, M. G. R., Steele, S. J., and Nabarro, J. D. V., 1976, Clinical and endocrine features of hyperprolactin-aemic amenorrhoea, Clin. Endocrinol. (Oxford) 5:439–454.Google Scholar
  61. 61.
    Archer, D. F., Sprong, J. W., Nankin, H. R., and Josimovich, J. B., 1976, Pituitary gonadotropin response in women with idiopathic hyperprolactine-mia, Fertil. Steril. 27:1158–1164.PubMedGoogle Scholar
  62. 62.
    Bohnet, H. G., Dahlén, H. G., Wuttke, W., and Schneider, H. P. G., 1976, Hyperprolactinemic anovulatory syndrome, J.Clin. Endocrinol. Metab. 42:132–143.PubMedGoogle Scholar
  63. 63.
    Mcintosh, E. N., 1976, Treatment of women with the galactorrhea-amenor-rhea syndrome with pyridoxine (vitamin B6), J.Clin. Endocrinol. Metab. 42:1192–1195.PubMedGoogle Scholar
  64. 64.
    Magrini, G., Ebiner, J. R., Burckhardt, P., and Felber, J. P., 1976, Study on the relationship between plasma prolactin levels and androgen metabolism in man, J.Clin. Endocrinol. Metab. 43:944–947.PubMedGoogle Scholar
  65. 65.
    Ambrosi, B., Travaglini, P., Beck-Peccoz, P., Bara, R., Elli, R., Paracchi, A., and Faglia, G., 1976, Effect of sulphiride-induced hyperprolactinemia on serum testosterone response to HCG in normal men, J.Clin. Endocrinol. Metab. 43:700–703.PubMedGoogle Scholar
  66. 66.
    Rubin, R. T., Poland, R. E., and Tower, B. B., 1976, Prolactin-related testosterone secretion in normal adult men, J.Clin. Endocrinol. Metab. 42:112–116.PubMedGoogle Scholar
  67. 67.
    Seppällä, M., Hirvonen, E., Unnérus, H. A., Ranta, T., and Laatikainen, T., 1976, Prolactin and testosterone: Independent circulating levels in hyperprolactinemic and normoprolactinemic amenorrhea. The effect of prolactin suppression by bromocriptine,J.Clin. Endocrinol. Metab. 43:198–200.Google Scholar
  68. 68.
    Delvoye, P., Delogne-Desnoeck, J., and Robyn, C., 1976, Serum-prolactin in long-lasting lactation amenorrhoea, Lancet 2:288–289.PubMedGoogle Scholar
  69. 69.
    Tyson, J. E., Perez, A., and Zanartu, J., 1976, Human lactational response to oral thyrotropin releasing hormone, J. Clin. Endocrinol. Metab. 43:760–768.PubMedGoogle Scholar
  70. 70.
    Yen, S. S. C., Rebar, R. W., and Quesenberry, W., 1976, Pituitary function in pseudocyesis, J. Clin. Endocrinol. Metab. 43:132–136.PubMedGoogle Scholar
  71. 71.
    Krieger, D. T., Howantiz, P. J., and Frantzy A. G., 1976, Absence of nocturnal elevation of plasma prolactin concentrations in Cushing’s disease, J. Clin. Endocrinol. Metab. 42:260–272.PubMedGoogle Scholar
  72. 72.
    Onishi, T., Miyai, K., Izumi, K., Nakanishi, H., and Kumahara, Y., 1975, Prolactin response to chlorpromazine and thyrotropin-releasing hormone in hyperthyroidism,J.Clin. Endocrinol. Metab. 40:30–32.PubMedGoogle Scholar
  73. 73.
    Onishi, T., Itoh, K. F., Miyai, K., Izumi, K., Shima, K., and Kumahara, Y., 1976, Prolactin response to arginine in normal subjects and in patients with hyperthyroidism, J.Clin. Endocrinol. Metab. 42:148–151.PubMedGoogle Scholar
  74. 74.
    Mills, J. B., Zeringue, M., Harris, R., Wilhelmi, A. E., and Rudman, D., 1976, Assay of pig growth hormone preparations for metabolic activities in the rat and in man,J.Clin. Endocrinol. Metab. 42:1127–1132.PubMedGoogle Scholar
  75. 75.
    Lewis, U. J., Pence, S. J., Singh, R. N. P., and VanderLaan, W. P., 1975, Enhancement of the growth promoting activity of human growth hormone, Biochem. Biophys. Res. Commun. 67:617–624.PubMedGoogle Scholar
  76. 76.
    Baumann, G., 1976, Failure of endogenous plasmin to convert human growth hormone to its “activated” isohormones, J.Clin Endocrinol. Metab. 43:222–225.PubMedGoogle Scholar
  77. 77.
    Baumann, G., and Hodgen, G., 1976, Lack of in vivo transformation of human growth hormone to its “activated” isohormones in peripheral tissues of the rhesus monkey,J.Clin. Endocrinol. Metab. 43:1009–1014.PubMedGoogle Scholar
  78. 78.
    Lesniak, M. A., Gorden, P., Roth, J., and Gavin, J. R., III, 1974, Binding of 125I-human growth hormone to specific receptors in human cultured lymphocytes,J.Biol. Chem. 249:1661–1667.PubMedGoogle Scholar
  79. 79.
    Carr, D., and Friesen, H. G., 1976, Growth hormone and insulin binding to human liver,J.Clin. Endocrinol. Metab. 42:484–493.PubMedGoogle Scholar
  80. 80.
    Kelly, P. A., Tsushima, T., Shiu, R. P. C., and Friesen, H. G., 1976, Lactogenic and growth hormone-like activities in pregnancy determined by radioreceptor assay, Endocńnology 99:765–774.Google Scholar
  81. 81.
    Mochizuki, M., Morikawa, H., Kawaguchi, K., and Tojo, S., 1976, Growth hormone, prolactin and chorionic somatomammotropin in normal and molar pregnancy,J.Clin. Endocrinol. Metab. 43:614–621.PubMedGoogle Scholar
  82. 82.
    Gerich, J. E., Lorenzi, M., Bier, D. M., Tsalikian, E., Schneider, V., Karam, J. H., and Forsham, P. H., 1976, Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin,J.Clin. Invest. 57:875–884.PubMedGoogle Scholar
  83. 83.
    Chambers, J. W., and Brown, G. M., 1976, Stimulation of rhesus monkey GH release: Arginine vs. plasma volume expansion,J.Clin. Endocrinol Metab. 42:169–172.PubMedGoogle Scholar
  84. 84.
    Pontiroli, A. E., Viberti, G. C., Tognetti, A., and Pozza, G., 1976, Effect of metergoline, a specific serotonin antagonist, on human growth hormone response to arginine and L-Dopa, Horm. Metab. Res. 8:106–108.PubMedGoogle Scholar
  85. 85.
    Malarkey, W. B., and Mendell, J. R., 1976, Failure of serotonin inhibitor to effect nocturnal GH and prolactin secretion in patients with Duchenne muscular dystrophy, J.Clin. Endocrinol. Metab. 43:889–892.Google Scholar
  86. 86.
    Brown, W. A., and Williams, B. W., 1976, Methylphenidate increases serum growth hormone concentrations,J.Clin. Endocrinol. Metab. 43:937–939.PubMedGoogle Scholar
  87. 87.
    Maeda, K., Kato, Y., Yamaguchi, N., Chihara, K., Ohgo, S., Iwasaki, Y., Yoshimoto, Y., Moridera, K., Kuromaru, S., and Imura, H., 1976, Growth hormone release following thyrotropin-releasing hormone injection into patients with anorexia nervosa, Acta Endocrinol. (Copenhagen) 81:1–8.Google Scholar
  88. 88.
    Herbai, G., and Werner, I., 1976, Sheehan’s syndrome of hypothalamic origin in a woman with juvenile diabetes mellitus, Acta Med. Scand. 199:539–541.PubMedGoogle Scholar
  89. 89.
    Korsgaard, O., Lindholm, J., and Rasmussen, P., 1976, Endocrine function in patients with suprasellar and hypothalamic tumours, Acta Endocrinol. (Copenhagen) 83:1–8.Google Scholar
  90. 90.
    Jenkins, J. S., Gilbert, C. J., and Ang, V., 1976, Hypothalamic-pituitary function in patients with cranio pharyngiomas, J.Clin. Endocrinol. Metab. 43:394–399.PubMedGoogle Scholar
  91. 91.
    Haymond, M. W., Karl, I., Weldon, V. V., and Pagliara, A. S., 1976. The role of growth hormone and cortisone on glucose and gluconeogenic substrate regulation in fasted hypopituitary children, J. Clin. Endocrinol. Metab. 42:846–856.PubMedGoogle Scholar
  92. 92.
    Jacobs, L. S., Sneid, D. S., Garland, J. T., Laron, Z., and Daughaday, W. H., 1976, Receptor-active growth hormone in Laron dwarfism,J.Clin. Endocrinol Metab. 42:403–406.PubMedGoogle Scholar
  93. 93.
    Clemons, R. D., Costin, G., and Kogut, M. D., 1976, Laron dwarfism: Growth and immunoreactive insulin following treatment with human growth hormone, J.Pediatr. 88:427–433.PubMedGoogle Scholar
  94. 94.
    Walsh, C. H., Wright, A. D., Williams, J. W., and Holder, G., 1976, A study of pituitary function in patients with idiopathic hemochromatosis, J. Clin. Endocrinol. Metab. 43:866–872.PubMedGoogle Scholar
  95. 95.
    Preece, M. A., Tanner, J. M., Whitehouse, R. H., and Cameron, N., 1976, Dose dependence of growth response to human growth hormone in growth hormone deficiency, J. Clin. Endocrinol. Metab. 42:477–483.PubMedGoogle Scholar
  96. 96.
    Pertzelan, A., Kauli, R., Assa, S., Greenberg, D., and Laron, Z., 1976, Intermittent treatment with human growth hormone (GH) in isolated GH deficiency and in multiple pituitary hormone deficiencies, Clin. Endocrinol. (Oxford) 5:15–24.Google Scholar
  97. 97.
    Aynsley-Green, A., Zachmann, M., and Prader, A., 1976, Interrelation of the therapeutic effects of growth hormone and testosterone on growth in hypopituitarism, J. Pediatr. 89:992–999.PubMedGoogle Scholar
  98. 98.
    Tanner, J. M., Whitehouse, R. H., Hughes, P. C. R., and Carter, B. S., 1976, Relative importance of growth hormone and sex steroids for the growth at puberty of trunk length, limb length, and muscle width in growth hormone-deficient children,J.Pediatr. 89:1000–1008.PubMedGoogle Scholar
  99. 99.
    Franks, S., Jacobs, H. S., and Nabarro, J. D., 1976, Prolactin concentrations in patients with acromegaly—clinical significance and response to surgery, Clin. Endocrinol. (Oxford) 5:63–69.Google Scholar
  100. 100.
    Corenblum, B., Sirek, A. M. T., Horvath, E., Kovacs, K., and Ezrin, C., 1976, Human mixed somato trophic and lacto trop hic pituitary adenomas, J. Clin. Endocrinol. Metab. 42:857–863.PubMedGoogle Scholar
  101. 101.
    Catania, A., Catalamessa, L. and Reschini, E., 1976, Plasma prolactin response to luteinizing hormone releasing hormone in acromegalic patients, J. Clin. Endocrinol. Metab. 43:689–691.PubMedGoogle Scholar
  102. 102.
    Debek, J. T., 1974, Bronchial carcinoid tumor with acromegaly in two patients,J.Clin. Endocrinol. Metab. 38:329–333.Google Scholar
  103. 103.
    Sönksen, P. H., Ayres, A. B., Braimbridge, M., Corrin, B., Davies, D. R., Jeremiah, G. M., Oaten, S. W., Lowy, C., and West, T. E.T., 1976, Acromegaly caused by pulmonary carcinoid tumours, Clin. Endocrinol. (Oxford) 5:503–13.Google Scholar
  104. 104.
    Gorden, P., Lesniak, M. A., Eastman, R., Hendricks, C. M., and Roth, J., 1976, Evidence for higher proportion of “little” growth hormone with increased radioreceptor activity in acromegalic plasma, J. Clin. Endocrinol. Metab. 43:364–373.PubMedGoogle Scholar
  105. 105.
    Delitala, G., Masala, A., Alagna, S., Devilla, L., and Lotti, G., 1976, Growth hormone and prolactin release in acromegalic patients following metergo-line administration,J.Clin. Endocrinol. Metab. 43:1382–1386.PubMedGoogle Scholar
  106. 106.
    Chiodini, P. G., Liuzzi, A., Muller, E. E., Botalla, L., Cremascoli, G., Oppizzi, G., Verde, G., and Silvestrini, F., 1976, Inhibitory effect of an ergoline derivative, metergoline, on growth hormone and prolactin levels in acromegalic patients, J. Clin. Endocrinol. Metab. 43:356–363.PubMedGoogle Scholar
  107. 107.
    Feldman, J. M., Plonk, J. W., and Bivens, C. H., 1976, Inhibitory effect of serotonin antagonists on growth hormone release in acromegalic patients, Clin. Endocrinol. (Oxford) 5:71–78.Google Scholar
  108. 108.
    Verde, G., Oppizzi, G., Colussi, G., Cremascoli, G., Botalla, L., Muller, E. E., Silverstrini, F., Chiodini, P. G., and Liuzzi, A., 1976, Effect of dopamine infusion on plasma levels of growth hormone in normal subjects and in agromegalic patients, Clin. Endocrinol. (Oxford) 5:419–423.Google Scholar
  109. 109.
    Lamberg, B. A., Pelkonen, R., Aro, A., and Grahne, B., 1976, Thyroid function in acromegaly before and after transsphenoidal hypophysectomy followed by cryoapplication, Acta Endocrinol. 82:254–266.PubMedGoogle Scholar
  110. 110.
    Sandler, R., 1976, Recurrent hyperthyroidism in an acromegalic patient previously treated with proton beam irradiation: Graves’ disease as probable etiology based on follow-up observations,J.Clin. Endocrinol. Metab. 42:163–168.PubMedGoogle Scholar
  111. 111.
    Hamilton, C. R., Jr., and Maloof, F., 1972, Acromegaly and toxic goiter. Cure of the hyperthyroidism and acromegaly by proton-beam partial hypophysectomy,J.Clin. Endocrinol. Metab. 35:659–664.PubMedGoogle Scholar
  112. 112.
    Nagulesparen, M., Trickey, R., Davies, M. J., and Jenkins, J. S., 1976, Muscle changes in acromegaly, Br. Med. J. 2:914–915.PubMedGoogle Scholar
  113. 113.
    Luft, R., and Hall, K. (eds.), 1975, Somatomedin and some other growth factors, in: Advances in Metabolic Disorders, Vol. 8, Academic Press, New York.Google Scholar
  114. 114.
    Rinderknecht, E., and Humbel, R. E., 1976, Amino-terminal sequences of two polypeptides from human serum with nonsuppressible insulin-like and cell-growth-promoting activities: Evidence for structural homology with insulin B chain, Proc. Natl. Acad. Sci. U.S.A. 73:4379–4381.PubMedGoogle Scholar
  115. 115.
    Schlumpf, U., Heimann, R., Zapf, J., and Froesch, E. R., 1976, Nonsuppressible insulin-like activity and sulphation activity in serum extracts of normal subjects, acromegalics and pituitary dwarfs, Acta Endocrinol. 81:28–42.PubMedGoogle Scholar
  116. 116.
    Franklin, R. C., Rennie, G. C., Burger, H. G., and Cameron, D. P., 1976, A bioassay for NSILA-S in individual serum samples and its relationship to somatotropin,J.Clin. Endocrinol. Metab. 43:1164–1169.PubMedGoogle Scholar
  117. 117.
    Garland, J. T., Jennings, J., Levtsky, L. I., and Buchanan, F., 1976, Stimulation of DNA synthesis in isolated chrondrocytes by somatomedin. II. Validation of the assay for clinical use and comparison with the stimulation of protein synthesis,J.Clin. Endocrinol. Metab. 43:847–851.PubMedGoogle Scholar
  118. 118.
    Garland, J. T., and Buchanan, F., 1976, Stimulation of RNA and protein synthesis in isolated chondrocytes by human serum, J. Clin. Endocrinol. Metab. 43:842–846.PubMedGoogle Scholar
  119. 119.
    Takano, K., Hall, K., Ritzen, M., Iselius, L., and Sievertsson, H., 1976, Somatomedin A in human serum, determined by radioreceptor assay, Acta Endocrinol. 82:449–459.PubMedGoogle Scholar
  120. 120.
    Furlanetto, R. W., D’Ercole, A. J., Underwood, L. E., and Van Wyk, J. J., 1976, A radioimmunoassay for somatomedin-C: Development, specificity and results, 5th International Congress of Endocrinology, Hamburg, Brühische Universitätsdruckerei, Giessen, Abstract No. 392.Google Scholar
  121. 121.
    Heinrich, U. E., Schalch, D. S., Koch, J. G., and Johnson, C. J., 1976, Nonsuppressible insulin-like activity (NSILA-s): Plasma levels and their relationship to growth hormone and NSILA-s carrier protein concentration, 5th International Congress of Endocrinology, Hamburg, Brühische Universitätsdruckerei, Giessen, Abstract No. 398.Google Scholar
  122. 122.
    Cohen, K. L., and Nissley, S. P., 1976, The serum half-life of somatomedin activity: Evidence for growth hormone dependence, Acta Endocrinol. 83:243–58.PubMedGoogle Scholar
  123. 123.
    D’Ercole, A. J., Foushee, D. B., and Underwood, L. E., 1976, Somatomedin-C receptor ontogeny and levels in porcine fetal and human cord serum, J. Clin. Endocrinol. Metab. 43:1069–1077.PubMedGoogle Scholar
  124. 124.
    Gluckman, P. D., and Brinsmead, M. W., 1976, Somatomedin in cord blood: Relationship to gestational age and birth size, J. Clin. Endocrinol. Metab. 43:1378–1381.PubMedGoogle Scholar
  125. 125.
    Giordano, G., Foppiani, E., Minuto, F., and Perroni, D., 1976, Growth hormone and somatomedin behaviour in the newborn, Acta Endocrinol. 81:449–454.Google Scholar
  126. 126.
    Bala, R. M., and Smith, G. R., 1976, Partial characterization of somatomedin bioactivity in term human amniotic fluid,J.Clin. Endocrinol. Metab. 43:907–912.PubMedGoogle Scholar
  127. 127.
    Chochinov, R. H., Ketupanya, A., Mariz, I. K., Underwood, L. E., and Daughaday, W. H., 1976, Amniotic fluid reactivity detected by somatomedin C radioreceptor assay correlation with growth hormone, prolactin and fetal renal maturation,J.Clin. Endocrinol. Metab. 42:983–986.PubMedGoogle Scholar
  128. 128.
    Chochinov, R. H., Mariz, I. K., Hajek, A. S., and Daughaday, W. H., 1977, Characterization of a protein in mid-term human amniotic fluid which reacts in the somatomedin-C radioreceptor assay, J.Clin. Endocrinol. Metab. 44:902–908.PubMedGoogle Scholar
  129. 129.
    Pierson, M., Grignon, G., Malaprade, D., and Hartemann, P., 1976, L àctivité somatomédine du sérum au cours de lènfance chez le sujet normal et dans les retards de croissance, Ann. Biol. Clin. 34:11–18.Google Scholar
  130. 130.
    Gluckman, P. D., and Holdaway, I. M., 1976, Prolactin and somatomedin studies in the syndrome of growth hormone-independent growth, Clin. Endocrinol. (Oxford) 5:545–549.Google Scholar
  131. 131.
    Costin, G, Kogut, M. D., Phillips, L. S., and Daughaday, W. H., 1976, Craniopharyngioma: The role of insulin in promoting postoperative growth, J.Clin. Endocrinol. Metab. 42:370–379.PubMedGoogle Scholar
  132. 132.
    Wiedemann, E., and Schwartz, E., 1972, Suppression of growth hormone-dependent human serum sulfation factor by estrogen, J. Clin. Endocrinol. Metab. 34:51–58.PubMedGoogle Scholar
  133. 133.
    Wiedemann, E., Schwartz, E., and Frantz, A. G., 1976, Acute and chronic estrogen effects upon serum somatomedin activity, growth hormone, and prolactin in man,J.Clin. Endocrinol. Metab. 42:942–952.Google Scholar
  134. 134.
    Saenger, P., Schwartz, E., Wiedemann, E., Levine, L. S., Tsai, M., and New, M. I., 1976, The interaction of growth hormone, somatomedin and oestrogen in patients with Turner’s syndrome, Acta Endocrinol. 81:9–18.PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1978

Authors and Affiliations

  • William H. Daughaday
    • 1
  1. 1.Metabolism Division, Department of MedicineWashington University School of MedicineUSA

Personalised recommendations